Author: Lynne Taylor

Sales of drugs to treat chronic heart failure are set to soar, from around $2.9 billion in 2013 to $8.9 billion in 2023, according to new forecasts.

The National Institute for Health and Care Excellence has published new draft guidance on medicines optimisation to ensure people get the best possible outcomes from the medicines they are prescribed.

The Scottish government has announced a doubling of funding this year, from £20 million to £40 million, to improve patient access to new medicines.

The UK leads Europe for the amount of bioscience innovation capital raised in first-half 2014, and it remains Europe’s largest bioscience cluster, with more than 450 product candidates developed in 2013, says a new report.

Pfizer is launching a new scratch card for patients, as part of its ongoing campaign to raise awareness of medicines optimisation.